Idexx Laboratories | IDXX - Gross Profit On Sales

Stock Price
644.61
Daily Change
1.02 0.16%
Monthly
-9.79%
Yearly
40.20%
Q1 Forecast
649.81

Idexx Laboratories reported $658.11M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
Dentsply International USD 441M 49M Sep/2025
Dexcom USD 688.8M 99.8M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Fujifilm JPY 347.51B 14.74B Dec/2025
Globus Medical USD 486.67M 725.06M Sep/2025
Henry Schein USD 1.03B 74M Sep/2025
Hologic USD 586.4M 2.9M Dec/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Insulet USD 510.1M 57.9M Sep/2025
Integra LifeSciences USD 206.99M 2.34M Sep/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
Masimo USD 230.6M 2.7M Sep/2025
Neogen USD 94.97M 2.11M Jun/2025
ResMed USD 878.72M 57.9M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Tandem Diabetes Care USD 134.29M 8.44M Sep/2025
Teleflex USD 451.64M 20.56M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Zoetis USD 1.72B 96M Sep/2025